Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes.

Staurosporine, a microbial alkaloid, is a strong inhibitor of protein kinases. The effects of staurosporine on the cell cycle progression and nuclear morphology of normal human lymphocytes stimulated to proliferate by phytohemagglutinin were studied and compared with the effects of this drug on human lymphocytic leukemic MOLT-4 cells. Exposure of normal lymphocytes to either 5-10 or 50-100 ng/ml of staurosporine resulted in the preferential accumulation of cells in G1 or G1 and G2 phases of the cell cycle, respectively. In contrast, regardless of the concentration (5-100 ng/ml), staurosporine arrested MOLT-4 cells initially in G2; these cells then initiated additional rounds of DNA replication, without division. Staurosporine (5-100 ng/ml) induced severe changes in the nuclear morphology of MOLT-4 cells, manifested as nuclear elongation, deep invaginations of the nuclear membrane, extensive fragmentation, and micronucleation. At concentrations of 5-10 ng/ml, staurosporine had no apparent effect on the nuclear morphology of normal lymphocytes and at 50-100 ng/ml it produced minor changes in the nuclear shapes of these cells. The data indicate that the kinase(s) involved in the regulation of cell exit from G1 and G2, respectively, in normal and leukemic lymphocytes may have different sensitivities to staurosporine, which suggests that the mechanisms controlling exit from G1 in these cells may be different. In MOLT-4 cells the staurosporine-sensitive kinase(s) appear to also be involved in phosphorylation of nuclear constituents essential for organization of gross chromatin structure. The different response of normal versus leukemic lymphocytes to staurosporine, if confirmed on clinical material, opens new strategies of tumor treatment.

[1]  Curt Wittenberg,et al.  G1-specific cyclins of S. cerevisiae: Cell cycle periodicity, regulation by mating pheromone, and association with the p34 CDC28 protein kinase , 1990, Cell.

[2]  T. Tamaoki,et al.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. , 1986, Biochemical and biophysical research communications.

[3]  S Omura,et al.  A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. , 1977, The Journal of antibiotics.

[4]  Z. Darżynkiewicz,et al.  Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. , 1990, Cancer research.

[5]  H. Feiler,et al.  Cell division in higher plants: a cdc2 gene, its 34-kDa product, and histone H1 kinase activity in pea. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Tony Hunter,et al.  Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 , 1989, Cell.

[7]  H. Iba,et al.  Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. , 1987, The Journal of antibiotics.

[8]  H. Crissman,et al.  Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Melamed,et al.  Lymphocyte stimulation: a rapid multiparameter analysis. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Piwnica-Worms,et al.  cdc2 gene expression at the G1 to S transition in human T lymphocytes. , 1990, Science.

[11]  J. Hayles,et al.  A review of mitosis in the fission yeast Schizosaccharomyces pombe. , 1989, Experimental cell research.

[12]  W. Ardelt,et al.  Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer Agent , 1988, Cell and tissue kinetics.

[13]  M. Yoshida,et al.  Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. , 1991, Experimental cell research.

[14]  D. Beach,et al.  A complex containing p34cdc2 and cyclin B phosphorylates the nuclear lamin and disassembles nuclei of clam oocytes in vitro , 1991, The Journal of cell biology.